Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This drug is a **combination of herbal extracts**: *Passiflora incarnata* (commonly known as passionflower), *Crataegus oxyacantha* (hawthorn), and *Salix alba* (white willow). These plants have traditionally been used in European phytotherapy formulations for their distinct properties. - **Passiflora incarnata** is primarily known for its sedative, anxiolytic (anti-anxiety), and hypnotic activities. It is used to manage insomnia, anxiety, nervousness, neuralgia, menopausal symptoms, and sometimes for mild pain. Mechanistically, evidence suggests that it modulates gamma-aminobutyric acid (GABA) in the central nervous system, resulting in a calming effect[1][2][3][4][5]. - **Crataegus oxyacantha** (hawthorn) is a cardiotonic herb widely used for supporting cardiovascular health, improving cardiac function, reducing blood pressure, and treating mild heart failure. It contains flavonoids and oligomeric procyanidins that may exert antioxidant, vasodilatory, and antiarrhythmic effects. - **Salix alba** (white willow) is a traditional source of salicin, a precursor to salicylic acid, with analgesic (pain-relieving), anti-inflammatory, and antipyretic (fever-reducing) properties. It acts through inhibition of cyclooxygenase enzymes (COX), similar to nonsteroidal anti-inflammatory drugs (NSAIDs). This combination is typically marketed as a *natural calming, cardiotonic, and anti-inflammatory remedy*, often in dietary supplements or herbal preparations for relief of anxiety, mild pain, stress, sleep disorders, mild circulatory problems, or menopausal symptoms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on passiflora incarnata + crataegus oxyacantha + salix alba.